Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2008 | 2 |
2009 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Phase II trial of temozolomide (TMZ) plus irinotecan (CPT-11) in adults with newly diagnosed glioblastoma multiforme before radiotherapy.
J Neurooncol. 2009 Dec;95(3):393-400. doi: 10.1007/s11060-009-9937-x. Epub 2009 Jun 17.
J Neurooncol. 2009.
PMID: 19533023
Free PMC article.
Clinical Trial.
Bevacizumab plus irinotecan in recurrent WHO grade 3 malignant gliomas.
Desjardins A, Reardon DA, Herndon JE 2nd, Marcello J, Quinn JA, Rich JN, Sathornsumetee S, Gururangan S, Sampson J, Bailey L, Bigner DD, Friedman AH, Friedman HS, Vredenburgh JJ.
Desjardins A, et al.
Clin Cancer Res. 2008 Nov 1;14(21):7068-73. doi: 10.1158/1078-0432.CCR-08-0260.
Clin Cancer Res. 2008.
PMID: 18981004
Free PMC article.
Clinical Trial.
Item in Clipboard
Mismatch repair deficiency does not mediate clinical resistance to temozolomide in malignant glioma.
Maxwell JA, Johnson SP, McLendon RE, Lister DW, Horne KS, Rasheed A, Quinn JA, Ali-Osman F, Friedman AH, Modrich PL, Bigner DD, Friedman HS.
Maxwell JA, et al.
Clin Cancer Res. 2008 Aug 1;14(15):4859-68. doi: 10.1158/1078-0432.CCR-07-4807.
Clin Cancer Res. 2008.
PMID: 18676759
Free PMC article.
Item in Clipboard
Cite
Cite